Acatinib 100 mg Tablet

Description

Acatinib 100 mg Tablet is a targeted anticancer agent used for specific types of cancer. It helps slow tumor growth by blocking key cellular pathways. Use only under specialist supervision.

Benefits

• Targets the specific molecular driver of cancer, enabling more focused therapy.

• Can slow or halt tumor growth and spread in eligible patients.

• Potential to improve progression-free survival when used appropriately.

• Oral tablet formulation offers convenience relative to some injectable therapies.

Indications and Usage

• Used for the treatment of [specific cancer type as per prescribing information; e.g., non-small cell lung cancer (NSCLC) with certain biomarkers].

• May be used when tumors exhibit particular molecular targets or mutations, as determined by diagnostic testing.

• Should be used in combination with other therapies as specified by the oncologist.

• Strictly for use under specialist cancer-treatment supervision.

How it Works

Acatinib targets and inhibits key signaling proteins that cancer cells rely on to grow and divide (for example, certain tyrosine kinases). By blocking these pathways, the drug disrupts the cancer’s growth mechanisms, leading to slowed tumor progression or cell death in susceptible tumors.

Dosage & Administration

• The typical dose is 100 mg tablet, taken as directed by the oncologist (e.g., once or twice daily depending on regimen).

• Take at the same time each day.

• Swallow whole with a full glass of water; may be taken with or without food unless advised otherwise.

• Do not modify or skip doses without consulting the specialist.

• Regular monitoring (blood tests, liver function, imaging studies) is required to evaluate response and manage toxicity.

Side Effects

Common side effects may include:

• Fatigue or weakness

• Nausea and/or vomiting

• Loss of appetite

• Diarrhea

• Skin rash or changes

Serious side effects (seek medical attention immediately):

• Severe liver enzyme elevation or liver injury

• Pulmonary problems (e.g., interstitial lung disease)

• Significant blood count abnormalities (e.g., neutropenia, thrombocytopenia)

• Severe allergic reactions

• Unexpected bleeding or clotting events

Warning and Precaution

• Use only if indicated by the specialist and if appropriate biomarker/mutation status is confirmed.

• Avoid in patients with known severe liver or kidney impairment unless specialist advises otherwise.

• Monitor for lung or respiratory symptoms; discontinue and investigate if interstitial lung disease suspected.

• Caution if history of bleeding, clotting or cardiovascular disease.

• Pregnancy & breastfeeding: not recommended unless clearly needed and supervised by oncology specialist.

• This medicine does not cure cancer; it is part of a broader treatment plan. Patients must discuss all risks, benefits and alternatives with their oncologist.